In the correlation analysis, ZBTB42 is positively related to the expression of CSF-1 in both LGG and GBM indicating ZBTB42 is associated with immune suppression in glioma and this feature may be related to the increased expression of CSF-1. Here, CSF1 is linked to central nervous system cancer.